Next, we retrovirally introduced all MYD88 variants in DLBCL cell lines OCI-LY1 and OCI-LY7, which endogenously express wildtype MYD88 and display very weak basal NF-κB activation. Here, MYD88 is linked to diffuse large B-cell lymphoma.